Pengaruh Kortikosteroid Intranasal (Fluticasone Furoate) Terhadap Interleukin – 5 (Il-5) Pada Polip Hidung
54
DAFTAR PUSTAKA
Aaron, Chandra,Conley, & Kern, 2010. Epidemiology of Nasal Polyps in
Nasal Polyposis. T.M.Onerci & B.J. Ferguson (eds), SpringerVerlag Berlin Heidelberg.
Assanasen, P. & Naclerio, R.M., 2001. Medical & Nasal surgical
management of nasal polyps in Current opinion in Otolaryngology
and Head and Neck Surgery. Lippincott William and Wilkins Inc, p.
27-36.
Bachert, C., Watelet, J.B., Gevaert, P.& Cauwenberge, P.V., 2005.
”Pharmacological Management of Nasal Polyposis.” Journal of Drug
sevaluation 66 (1): 1537-1552.
Bachert, C., 2011. ”Evidence-Based Management of Nasal Polyposis by
Intranasal Corticokortikosteroids: From the cause to the clinic.”
International Archieves of Allergy-Immunology (155): 309-21.
Badia, L., & Lund, V., 2001. ”Topical Corticosteroids in Nasal Polyposis.”
Journal of Drugsevaluation61 (5): 573-578.
Burgel, Cardell, Ueki, & Nadel, 2004. “Intranasal steroids decrease
eosinophils but not mucin expression innasal polyps” Eur Respir J
2004; 24: 594–600.
Corey, J.P. & Yilmaz, A.S., 2009. Assessment of Nasal Function in:
Ballenger’s Otorhinolaryngology. BC Decker Inc, Connecticut, 17th
ed, vol 2, p. 493-9.
Dewi, F., 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Magister Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU.
Djupesland, P.G., VLckova, I. & Hewson, G., 2010. “Impact of baseline
nasal polyp size and previous surgery of efficacy of fluticasone
delivered with a novel device: A subgroup analysis.” American
Journal of Rhinology and Allergy (24): 291-5.
Ebbens, F.A., Maldonado, M.,de Groot, E.J.J., Alobid, I.,Drunen, C.M.,
Picado. C.,Fokkens, W.J. & Mullol, J., 2009. “Topical
glucocorticoids downregulate COX-1 positive cells in nasal polyps
”Allergy 2009: 64: 96–103 _ 2008
Farrukh, M.S., Rafique,M. & Shaikh, A.A., 2014. “An Experience of Steroid
in Recurrent Ethmoidal Nasal Polypsat Tertiary Care Hospital”
JLUMHS JANUARY- APRIL 2014; Vol 13: No. 01 09.
Ferguson, B.J. & Orlandi, R.R., 2006. Chronic Hypertrophic Rhinosinusitis
and Nasal Polyposis in: Head & Neck Surgery Otolaryngology.
Lippincot Williams & Wilkins, 4th ed, Vol 1, p.1-25.
Ferrer, J.R., Pujols, L., Perez, M., Fuentes, M., Callejas, F.B., Alobis, I.,
Valero, A., Picado, C. and Mullol, J., 2013.“Fluticasone Furoate
55
Decreases Nasal Eosinophilic Inflammation by Inhibiting Both
Cytokine Secretion From Nasal Mucosa Epithelial Cells Cytokine
Secretion and Eosinophil Survival”Allergy Clin Immunol
Fisher,1992.
”Pharmacokinetics
and
Pharmacodynamics
of
Methylprednisolone when Administered at 8 AM versus 4 PM.”
Journal of Clinical Pharmacology Therapy 51: 677-88.
Gevaert, P., Cauwenberge, P.V. and Bachert, C., 2004. Figure of
Eosinophils in the Pathophysiology of Nasal Polyposis and the
Impact of OralCorticokortikosteroid Treatment (GCS). Thesis
submitted as partial fulfilment of the requirements for the degree of
doctor in medical sciences. Upper airways Research
Laboratory,Department of Otorhinolaryngology, Ghent University
Hospital, Belgium.
Hellquist, H.B., 1996. ”Histopathology.” Journal of Allergy and Asthma 17
(5): 237-240.
Holford & Benet, 2005. Farmakokinetik dan Farmakodinamik: Pemilihan
Dosis yang Rasional dan Waktu Kerja Obat dalam: Farmakologi
Dasar dan Klinik, EGC, Jakarta, edisi 10, h. 41-42.
Hwang, P.H. & Abdal khani, A., 2009. Embryology, Anatomy and
Physiology of the nose and Paranasal Sinuses in: Ballenger’s
Otorhinolaryngology. BC Decker Inc, Connecticut, 17th ed, Vol 2, p.
455-63.
Jankowski, R., Bouchoua, F., Coffinet, L.& Vignaud, J.M., 2002. ”Clinical
factor influencing the eosinophil infiltration of nasal polyps.”
American Journal of Rhinology (40): 173-8.
Jόkύti, 2008. Studying histamine, IL-5, IgE and TGF-beta1 in the
pathogenesis of nasal polyposis. Ph.D. dissertation. Semmelweis
University, Budapest.
Jonathan corren, 2012. “ Inhibition of interleukin-5 for the threatment of
eosinophilic.” Discov med 13 (71) 305-312 April 2012.
Kirtsreesakul, V., 2005. ”Update on Nasal Polyps: Etiopatogenesis.”
Journal
Medical Association Thailand 88 (12): 1966-72.
Kowalski, M.L., 2011. ”Oral and Nasal Kortikosteroids for Nasal Polyps.”
Poland Journal of Allergy and Asthma (11): 187-8.
Kumar, R., Kumar, D. & Parakh, A., 2011. ”Fluticasone furoate: A new
intranasal corticokortikosteroid.” Journal of Postgraduate Medicine
(58): 79-83.
Kwang O.Y., 2013. “Current Understanding and Management of Nasal
Polyps.” Medical Grapevine: The Knowledge Bettwen GPs
Specialists.
56
Lund, V.J., 1995. Diagnosis and treatment of nasal polyps.” British Medical
Journal (31): 1411-4.
Mangunkusumo, E. & Wardani, R.S., 2007. Polip Hidung dalam: Buku Ajar
Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D., 2008. Histopathology Types of Polyposis in Adam Malik
Hospital. Majalah Kedokteran Nusantara, vol.1, h. 1-3.
Mudassir, Azis, A. & Punagi, A.G., 2012. “Analisis Kadar Malondialdehid (
Mda ) PlasmaPenderita Polip Hidung Berdasarkan DominasiSel
Inflamasi Pada Pemeriksaan Histopatologi.” Bagian Ilmu Kesehatan
Telinga Hidung Tenggorok – Kepala LeherFakultas Kedokteran
Universitas Hasanuddin, Makassar.
Mulyamin, W., Azis, A. & Punagi, A.G., 2012. “Pengaruh Terapi Steroid
Intranasal Pada Penderita Rinitis Alergi Di Makassar. Tinjauan
Pada Aspek; Transpor Mukosiliar, Perbaikan Klinis Dan Kualitas
Hidup.” Bagian THT-KL, Fakultas Kedokteran, Universitas
Hasanuddin, Makassar.
Mullol J & Alobid I., 2012. “Role of Medical Therapy in the Management of
Nasal Polyps” Curr Allergy Asthma Rep (2012) 12:144–153.
Mostafa, H.S., Fawzy, T.O., Ayad, E. & Soliman, A.A., 2013. “Effect of a
prolonged topical glucocorticosteroid on interleukin-5 production
and eosinophilic recruitment in the nasal submucosal
compartment.” The Egyptian Journal of Otolaryngology, 29:151–
155
Mygind, N. and Lildholdt, T., 1996. “Nasal Polyps Treatment: Medical
Management.” American Journal of Allergy and Asthma, vol. 17,
(5): 275-80.
Newton, J.R. and Ah-See, K.W., 2008. ”A riview of nasal polyposis.”
Therapeutic and Clinical Risk Management (2): 507-512.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di
Indonesia.
Peric, Vojvodic, Durdevic, & Baletic, 2011. ”Correlation between cytokine
levels in nasal fluid and eosinophil.” AllergolImmunopathol (Madr).
Piromchai, P., Kasemsiri, P., Laohasiriwong,S. And Thanaviratananich, S.,
2013.“Chronic
rhinosinusitis
and
emergingtreatment
options”International Journal of General Medicine
Pornsuriyasak,
P.
&
Assanasen,
P.,
2008.
“Intranasal
Corticokortikosteroids .” Journal of Siriraj Med (60): 90-5.
Potter, P.C& Pawankar , R.,2012. “Indications, Efficacy, and Safety of
Intranasal Corticosteriods in Rhinosinusitis.” WAO Journal.
57
Rui, 2002. “Concentration, distribution and expression of interleukin-5 in
human nasal polyp tissues.” Chinese Medical Journal (9): 1386-9.
Sastre, J. and Mosges, R., 2012. “Local and Systemic Safety of Intranasal
Corticokortikosteroids.” Journal Investigation Allergol Clinical
Immunology (1): 1-12.
Shun, 2005. ”C-C Chemokine Ligand 2 Gene Expression in Nasal Polyp
Fibroblast: Possible Implication in the Pathogenesis of Nasal
Polyposis.” The Annals of Otology, Rhinology and Laryngology (11):
879.
Soetjipto, D., Mangunkusumo, E. and Wardani, R.S., 2007. Hidung dalam:
Buku Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan
Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Wang, D.Y., 2008. “Significance of Susceptible Gene ExpressionProfiles in
Nasal Polyposis” Clinical and Experimental Otorhinolaryngology
Vol. 1, No. 4: 177-183.
Watanabe, K., Kanaizumi, E., Shirasaki, H.& Himi, T. “Effects of
Glucocorticoids on Infiltrating Cells and Epithelial Cells of Nasal
Polyps.” The Annals of Otology, Rhinology and Laryngology (6):
465-72.
DAFTAR PUSTAKA
Aaron, Chandra,Conley, & Kern, 2010. Epidemiology of Nasal Polyps in
Nasal Polyposis. T.M.Onerci & B.J. Ferguson (eds), SpringerVerlag Berlin Heidelberg.
Assanasen, P. & Naclerio, R.M., 2001. Medical & Nasal surgical
management of nasal polyps in Current opinion in Otolaryngology
and Head and Neck Surgery. Lippincott William and Wilkins Inc, p.
27-36.
Bachert, C., Watelet, J.B., Gevaert, P.& Cauwenberge, P.V., 2005.
”Pharmacological Management of Nasal Polyposis.” Journal of Drug
sevaluation 66 (1): 1537-1552.
Bachert, C., 2011. ”Evidence-Based Management of Nasal Polyposis by
Intranasal Corticokortikosteroids: From the cause to the clinic.”
International Archieves of Allergy-Immunology (155): 309-21.
Badia, L., & Lund, V., 2001. ”Topical Corticosteroids in Nasal Polyposis.”
Journal of Drugsevaluation61 (5): 573-578.
Burgel, Cardell, Ueki, & Nadel, 2004. “Intranasal steroids decrease
eosinophils but not mucin expression innasal polyps” Eur Respir J
2004; 24: 594–600.
Corey, J.P. & Yilmaz, A.S., 2009. Assessment of Nasal Function in:
Ballenger’s Otorhinolaryngology. BC Decker Inc, Connecticut, 17th
ed, vol 2, p. 493-9.
Dewi, F., 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010. Tesis Magister Ilmu Kesehatan Telinga, Hidung, Tenggorok,
Bedah Kepala dan Leher. FK USU.
Djupesland, P.G., VLckova, I. & Hewson, G., 2010. “Impact of baseline
nasal polyp size and previous surgery of efficacy of fluticasone
delivered with a novel device: A subgroup analysis.” American
Journal of Rhinology and Allergy (24): 291-5.
Ebbens, F.A., Maldonado, M.,de Groot, E.J.J., Alobid, I.,Drunen, C.M.,
Picado. C.,Fokkens, W.J. & Mullol, J., 2009. “Topical
glucocorticoids downregulate COX-1 positive cells in nasal polyps
”Allergy 2009: 64: 96–103 _ 2008
Farrukh, M.S., Rafique,M. & Shaikh, A.A., 2014. “An Experience of Steroid
in Recurrent Ethmoidal Nasal Polypsat Tertiary Care Hospital”
JLUMHS JANUARY- APRIL 2014; Vol 13: No. 01 09.
Ferguson, B.J. & Orlandi, R.R., 2006. Chronic Hypertrophic Rhinosinusitis
and Nasal Polyposis in: Head & Neck Surgery Otolaryngology.
Lippincot Williams & Wilkins, 4th ed, Vol 1, p.1-25.
Ferrer, J.R., Pujols, L., Perez, M., Fuentes, M., Callejas, F.B., Alobis, I.,
Valero, A., Picado, C. and Mullol, J., 2013.“Fluticasone Furoate
55
Decreases Nasal Eosinophilic Inflammation by Inhibiting Both
Cytokine Secretion From Nasal Mucosa Epithelial Cells Cytokine
Secretion and Eosinophil Survival”Allergy Clin Immunol
Fisher,1992.
”Pharmacokinetics
and
Pharmacodynamics
of
Methylprednisolone when Administered at 8 AM versus 4 PM.”
Journal of Clinical Pharmacology Therapy 51: 677-88.
Gevaert, P., Cauwenberge, P.V. and Bachert, C., 2004. Figure of
Eosinophils in the Pathophysiology of Nasal Polyposis and the
Impact of OralCorticokortikosteroid Treatment (GCS). Thesis
submitted as partial fulfilment of the requirements for the degree of
doctor in medical sciences. Upper airways Research
Laboratory,Department of Otorhinolaryngology, Ghent University
Hospital, Belgium.
Hellquist, H.B., 1996. ”Histopathology.” Journal of Allergy and Asthma 17
(5): 237-240.
Holford & Benet, 2005. Farmakokinetik dan Farmakodinamik: Pemilihan
Dosis yang Rasional dan Waktu Kerja Obat dalam: Farmakologi
Dasar dan Klinik, EGC, Jakarta, edisi 10, h. 41-42.
Hwang, P.H. & Abdal khani, A., 2009. Embryology, Anatomy and
Physiology of the nose and Paranasal Sinuses in: Ballenger’s
Otorhinolaryngology. BC Decker Inc, Connecticut, 17th ed, Vol 2, p.
455-63.
Jankowski, R., Bouchoua, F., Coffinet, L.& Vignaud, J.M., 2002. ”Clinical
factor influencing the eosinophil infiltration of nasal polyps.”
American Journal of Rhinology (40): 173-8.
Jόkύti, 2008. Studying histamine, IL-5, IgE and TGF-beta1 in the
pathogenesis of nasal polyposis. Ph.D. dissertation. Semmelweis
University, Budapest.
Jonathan corren, 2012. “ Inhibition of interleukin-5 for the threatment of
eosinophilic.” Discov med 13 (71) 305-312 April 2012.
Kirtsreesakul, V., 2005. ”Update on Nasal Polyps: Etiopatogenesis.”
Journal
Medical Association Thailand 88 (12): 1966-72.
Kowalski, M.L., 2011. ”Oral and Nasal Kortikosteroids for Nasal Polyps.”
Poland Journal of Allergy and Asthma (11): 187-8.
Kumar, R., Kumar, D. & Parakh, A., 2011. ”Fluticasone furoate: A new
intranasal corticokortikosteroid.” Journal of Postgraduate Medicine
(58): 79-83.
Kwang O.Y., 2013. “Current Understanding and Management of Nasal
Polyps.” Medical Grapevine: The Knowledge Bettwen GPs
Specialists.
56
Lund, V.J., 1995. Diagnosis and treatment of nasal polyps.” British Medical
Journal (31): 1411-4.
Mangunkusumo, E. & Wardani, R.S., 2007. Polip Hidung dalam: Buku Ajar
Ilmu Kesehatan Telinga, Hidung Tenggorok, Kepala dan Leher.
Balai Penerbit FKUI, Jakarta, edisi keenam, h. 123-5.
Munir, D., 2008. Histopathology Types of Polyposis in Adam Malik
Hospital. Majalah Kedokteran Nusantara, vol.1, h. 1-3.
Mudassir, Azis, A. & Punagi, A.G., 2012. “Analisis Kadar Malondialdehid (
Mda ) PlasmaPenderita Polip Hidung Berdasarkan DominasiSel
Inflamasi Pada Pemeriksaan Histopatologi.” Bagian Ilmu Kesehatan
Telinga Hidung Tenggorok – Kepala LeherFakultas Kedokteran
Universitas Hasanuddin, Makassar.
Mulyamin, W., Azis, A. & Punagi, A.G., 2012. “Pengaruh Terapi Steroid
Intranasal Pada Penderita Rinitis Alergi Di Makassar. Tinjauan
Pada Aspek; Transpor Mukosiliar, Perbaikan Klinis Dan Kualitas
Hidup.” Bagian THT-KL, Fakultas Kedokteran, Universitas
Hasanuddin, Makassar.
Mullol J & Alobid I., 2012. “Role of Medical Therapy in the Management of
Nasal Polyps” Curr Allergy Asthma Rep (2012) 12:144–153.
Mostafa, H.S., Fawzy, T.O., Ayad, E. & Soliman, A.A., 2013. “Effect of a
prolonged topical glucocorticosteroid on interleukin-5 production
and eosinophilic recruitment in the nasal submucosal
compartment.” The Egyptian Journal of Otolaryngology, 29:151–
155
Mygind, N. and Lildholdt, T., 1996. “Nasal Polyps Treatment: Medical
Management.” American Journal of Allergy and Asthma, vol. 17,
(5): 275-80.
Newton, J.R. and Ah-See, K.W., 2008. ”A riview of nasal polyposis.”
Therapeutic and Clinical Risk Management (2): 507-512.
PERHATI-KL. 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di
Indonesia.
Peric, Vojvodic, Durdevic, & Baletic, 2011. ”Correlation between cytokine
levels in nasal fluid and eosinophil.” AllergolImmunopathol (Madr).
Piromchai, P., Kasemsiri, P., Laohasiriwong,S. And Thanaviratananich, S.,
2013.“Chronic
rhinosinusitis
and
emergingtreatment
options”International Journal of General Medicine
Pornsuriyasak,
P.
&
Assanasen,
P.,
2008.
“Intranasal
Corticokortikosteroids .” Journal of Siriraj Med (60): 90-5.
Potter, P.C& Pawankar , R.,2012. “Indications, Efficacy, and Safety of
Intranasal Corticosteriods in Rhinosinusitis.” WAO Journal.
57
Rui, 2002. “Concentration, distribution and expression of interleukin-5 in
human nasal polyp tissues.” Chinese Medical Journal (9): 1386-9.
Sastre, J. and Mosges, R., 2012. “Local and Systemic Safety of Intranasal
Corticokortikosteroids.” Journal Investigation Allergol Clinical
Immunology (1): 1-12.
Shun, 2005. ”C-C Chemokine Ligand 2 Gene Expression in Nasal Polyp
Fibroblast: Possible Implication in the Pathogenesis of Nasal
Polyposis.” The Annals of Otology, Rhinology and Laryngology (11):
879.
Soetjipto, D., Mangunkusumo, E. and Wardani, R.S., 2007. Hidung dalam:
Buku Ajar Ilmu Kesehatan Telinga, Hidung, Tenggorok, Kepala dan
Leher. Balai Penerbit FKUI, Jakarta, edisi keenam, h. 118-22.
Wang, D.Y., 2008. “Significance of Susceptible Gene ExpressionProfiles in
Nasal Polyposis” Clinical and Experimental Otorhinolaryngology
Vol. 1, No. 4: 177-183.
Watanabe, K., Kanaizumi, E., Shirasaki, H.& Himi, T. “Effects of
Glucocorticoids on Infiltrating Cells and Epithelial Cells of Nasal
Polyps.” The Annals of Otology, Rhinology and Laryngology (6):
465-72.